Іздеу

Шығарылым
Атауы
Авторлар
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V., Shatalova O., Klykova M., Stetsky N.
The use of angiotensin II type 1 receptor antagonists in the treatment of chronic heart failure against the background of the renin-angiotensin-aldosterone system genetic polymorphisms
Izmozherova N., Grenaderova M., Shambatov M., Popov A., Kudryavtseva E., Bortnik A., Vishneva K., Shamilov M.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.
Modern methods of treatment of elderly patients with chronic heart failure: a literature review
Kurochkina O., Baranov A., Sazhina A., Bogomolov A.
Risk factors of drug-induced diseases. Part 2. Comorbid diseases and lifestyle factors
Sychev D., Ostroumova O., Pereverzev A., Kochetkov A., Klepikova M., Ebzeeva E., De V.
Ishemicheskaya bolezn' serdtsa. Khronicheskaya obstruktivnaya bolezn' legkikh. Serdechnaya nedostatochnost' i dykhatel'naya nedostatochnost': differentsial'naya diagnostika, lechenie
Tatarskiy A., Kirillova D.
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
Karoli N., Rebrov A.
PERIPARTUM CARDIOMYOPATHY: 10-YEAR CLINICAL FOLLOW-UP
Sergeeva V., Eliseeva S., Zhuravleva E.
BISOPROLOL IN THE TREATMENT OF CHRONIC HEART FAILURE
Ogarkov M., Kovaleva Y., Mulerova T.
VLIYaNIE AKTOVEGINA NA FAGOTsITY KROVI PRI OKSIDATIVNOM STRESSE U PATsIENTOV S SERDEChNOY NEDOSTATOChNOST'Yu
Astashkin E., Glezer M., Orekhova N., Egorova N., Grachev S., Sokolova I.
KARDIOLOGIChESKIY BOL'NOY S ANEMIEY
Dvoretskiy L., Dyatlov N.
ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE
Dvoretskiy L., Dyatlov N., Dvoretsky L., Dyatlov N.
Possibilities for the correction of carbohydrate metabolism disturbances and 24 hours blood pressure profile in patients with chronic heart insufficiency and metabolic syndrome
Adamchik A., Kryuchkova I., Adamchik A., Kruchkova I.
Approaches to choosing a direct oral anticoagulant in the treatment of polymorbid patients with atrial fibrillation
Ostroumova O., Kochetkov A., Batyukina S., Lyakhova N.
Diurethic resistance: mechanisms, medical tactics and prevention
Dyadyk A., Kugler T., Schukina E., Rakitskaya I., Zborovsky S., Suliman Y.
TAURINE IN THE COMPLEX TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
Abduragimov S., Tepiovs N., Volov N., Sofrina S., Benevskaya M.
VOZMOZhNOSTI DIBIKORA V KORREKTsII METABOLIChESKIKh I SOSUDISTYKh NARUShENIY U BOL'NYKh KhRONIChESKOY SERDEChNOY NEDOSTATOChNOST'Yu I SAKhARNYM DIABETOM 2 TIPA
Statsenko M., Vinnikova A., Shilina N., Ronskaya A.
Vliyanie rozuvastatina na strukturnofunktsional'noe sostoyanie endoteliya u bol'nykh khronicheskoy serdechnoy nedostatochnost'yu ishemicheskoy etiologii
Bochenina Y., Kuznetsov G., Tenchurina L.
MODERN POTENTIALS FOR CORRECTION OF ACTIVITY OF NEUROHUMORAL SYSTEMS IN PATIENTS WITH MYOCARDIAL INFARCTION
Kokorin V., Volov N., Kokorin V., Volov N.
Algorithm of diuretics prescription in chronic heart failure: Diuver as loop diuretic of new generation
Strok A., Belousov Y., Strok A., Belousov Y.
Left ventricle dysfunction and its determinants in patients with ST-segment elevation acute myocardial infarction
Lebedev P., Verbovoy A., Mateesku K., Aleksandrov M., Povalayeva R.
INCREASED THYROID-STIMULATING HORMONE LEVEL AS A MARKER OF PROGRESSION OF HEART FAILURE IN CARDIAC PATIENTS
Adamchik A., Panchenko D.
Tipichnye oshibki pri lechenii khronicheskoy serdechnoy nedostatochnosti so snizhennoy sistolicheskoy funktsiey serdtsa u detey
Basargina E., Arkhipova E., Zharova O.
Lekarstvennye preparaty dlya lecheniya legochnoy gipertenzii
Ushkalova E., Runikhina N., Novikova I.
EFFICACY OF OMEGA-3 POLYUNSATURATED FATTY ACID FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES: CURRENT STATE OF THE PROBLEM
Gilyarevskiy S., Gilyarevsky S.
Nonselective beta-adrenoblocker carvedilol with vasodilating properties in the therapy of cardiovascular diseases
Maneshina O., Belousov Y., Maneshina O., Belousov Y.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
The use of statines in patients with arterial hypertension and chronic heart failure with preserved left ventricular ejection fraction
Kanorsky S., Sereda A.
Nebivolol v lechenii patsientov s khronicheskoy serdechnoy nedostatochnost'yu
Shalaev S., Kremneva L., Abaturova O.
Dinamika markerov sistemnogo vospaleniya u bol'nykh khronicheskoy serdechnoy nedostatochnost'yu ishemicheskoy etiologii na fone lecheniya rozuvastatinom
Bochenina Y., Kuznetsov G., Tenchurina L.
Zhelezodefitsit v kardiologii - novyy podkhod k staroy probleme?
Kopylov F.
FEATURES OF HEART AND VASCULAR REMODELING IN PATIENTS WITH STABLE ANGINA AND CHRONIC HEART FAILURE DURING 6-MONTH TREATMENT WITH IVABRADINE
Kosheleva N., Rebrov A., Kosheleva N., Rebrov A.
Dobutamine in the treatment of circulatory stroke
Shilov A., Shilov A.
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
Nikiforov V.
CLINICAL CASE OF TRANSTHYRETIN AMYLOIDOSIS WITH HEART, PLEVURE AND KIDNEY INVOLVEMENT
Ivanova M., Bolduyeva S., Ikonnikov P.
Osobennosti remodelirovaniya levogo zheludochka i razvitiya khronicheskoy serdechnoy nedostatochnosti u bol'nykh, perenesshikh infarkt miokarda, s uchetom sposoba revaskulyarizatsii i priverzhennosti terapii
Chesnikova A., Godunko E., Khripun A., Terent'ev V.
Profilaktika tromboembolicheskikh oslozhneniy u patsientov s khronicheskoy serdechnoy nedostatochnost'yu
Napalkov D., Sokolova A., Zhilenko A.
Khronicheskaya serdechnaya nedostatochnost' u bol'nykh sakharnym diabetom: sovremennye predstavleniya
Ettinger O.
New options for beta-adrenoblockers use: specific carvedilol's properties
Napalkov D., Seidova N., Napalkov D., Seidova N.
In spite of criticism, beta- beta-blockers remain preparations of selection in the treatment of the cardiovascular diseases
Makolkin V., Makolkin V.
Possibilities of using trimetazidine in the treatment of patients with ischemic heart disease and chronic heart failure
Polyakova O., Chochua A., Golovina O., Mironova E., Ostroumova O.
Role of copper in the development of cardiovascular pathology in patients with diffuse-toxic goiter
Kvitkova L., Vinichenko D., Borodkina D., Zinchuk S.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.
Rol' razlichnykh vidov renin-angiotenzinovoy sistemy v patogeneze serdechno-sosudistykh zabolevaniy. Fokus na valsartan
Astashkin E., Glezer M.
Serelaksin: novaya nadezhda na revolyutsionnyy proryv v lechenii ostroy serdechnoy nedostatochnosti
Ushkalova E.
ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE
Napalkov D., Panferov A., Napalkov D., Panferov A.
CLINICAL AND STATISTICAL SIGNIFICANCE OF RESULTS OF CLINICAL TESTS AS CRITERIA FOR THE BETA-BLOCKER SELECTION FOR THE TREATMENT OF CHRONIC HEART FAILURE
Gilyarevsky S., Kuzmina I., Gilyarevskiy S., Kuz'mina I.
Features of glycemic control in patients with type 2 diabetes mellitus and chronic heart failure
Demidova T., Titova V.
IVABRADIN AGAINST BISOPROLOL IN PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED LEFT VENTRICULAL EJECTION FRACTION
Kanorsky S., Borisenko Y.
Effektivnost' terapii bol'nykh khronicheskoy serdechnoy nedostatochnost'yu i narusheniyami ritma serdtsa preparatom Tsitokhrom S
Semenova I., Ballyuzek M., Novikov Y., Tugusheva F.
OMEGA-3 POLYUNSATURATED FATTY ACIDS: TOWARDS A STATUS OF SELF-DIRECTED STRATEGY FOR IMPROVING THE CARDIOVASCULAR PROGNOSIS
Fomin V., Fomin V.
CORRELATION OF CARDIOHEMODYNAMICS INDICES, INFLAMMATORY CYTOKINES LEVELS AND DEPRESSIVE DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE
Averin E., I Chernova S., Averin E., Chernova S.
Evaluation of the effect of bisoprolol and carvedilol on the functional status of patients with chronic heart failure and preserved left ventricular ejection fraction
Tregubov V., Khilkevich P., Shubitidze I., Tregubova M.
CLINICAL CASE OF SEVERE MYOCARDIAL DAMAGE IN A PATIENT WITH GIPOPITUITARISM
Sergeeva V., Zhukova E., Bogdalova L., Kharkova Y.
NEW EUROPEAN GUIDELINES ON PHARMACOTHERAPY OF CHRONIC HEART FAILURE AND EVIDENCE-BASED DATA
Larina V., Leonova M., Chukaeva I.
BISOPROLOL I KhRONIChESKAYa SERDEChNAYa NEDOSTATOChNOST'
Kirichenko A.
TsITOPROTEKTsIYa V KARDIOLOGII: MIF ILI REAL'NOST'?
Napalkov D., Zhilenko A.
LOOP DIURETICS: WHETHER THE WELL-ESTABLISHED STANDARD OF CARE NEEDS REFORM?
Pulin A., Kustova T., Fomin V., Pulin A., Kustov T., Fomin V.
Нәтижелер 58 - 1/58
Сыбырсөздер:
  • Негізгі сөздер тіркелімге сезімтал< / li>
  • Ағылшын предлогтары мен одақтары еленбейді
  • Әдепкі бойынша іздеу барлық негізгі сөздер үшін жасалады (агенс AND экспериенцер)
  • Белгілі бір терминді табу үшін OR қолданыңыз. білім беру OR оқыту
  • мысалы, күрделі сөз тіркестерін жасау үшін жақшаларды қолданыңыз. мұрағат ((журналдар OR конференциялар) NOT диссертациялар)
  • Нақты фразаны табу үшін, мысалы, тырнақшаларды қолданыңыз. "ғылыми зерттеулер"
  • сөзді - (сызықша) немесе not операторының көмегімен алып тастаңыз; мысалы. сұлулық байқауы< / em > немесе сұлулық байқауы< / em > < / li>
  • мысалы, нұсқа ретінде * қолданыңыз. ғылым* "ғылыми","ғылыми"және т. б. сөздерді қамтиды< / li> < / < / к-сі>

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>